Pharmaceuticals

Teva Pharmaceutical Industries Ltd. (TEVA) recently announced encouraging results on its multiple sclerosis candidate, laquinimod. Initial data on laquinimod, which is being developed with Active Biotech, indicated that patients treated with laquinimod experienced a statistically significant...

Shares of Amarin Corporation plc (Nasdaq: AMRN) are trading up 8.4% at $6.42 per share during the Wednesday afternoon trading session. The day's trading range for shares of Amarin Corporation plc has been between $5.85 and a 52-week high of $6.65 per share. Analysts covering Amarin Corporation plc...

Shares of ViroPharma Incorporated (NASDAQ: VPHM) are higher on the session by 3.32%, trading at $17.42. Overall put volume is now running at 18.81x the daily average, with 52% of all puts traded being purchases on the offer. 1,110 contracts have traded on the session so far. ViroPharma...

Shares of Biodel Inc. (NASDAQ: BIOD) are higher on the session by 0.92%, trading at $1.645. Overall put volume is now running at 2.14x the daily average, with 45% of all puts traded being purchases on the offer. 1,672 contracts have traded on the session so far. Biodel Inc. is a development-stage...

The broader markets are solidly negative, but despite this, there are some large cap stocks that are outperforming today, for a variety of reasons. There are also a handful of stocks that are being hit sharply. Novartis (NYSE: NVS) is up around 5% on news that the company is completing its...

The Consumer Price Index (CPI) rose by just 0.1% in November, down from 0.2% October. Even with the 0.1% increase in September, year over year it is up just 1.1%. Energy prices, were surprisingly well behaved in the month, rising just 0.2% after having surged 2.6% in October on top of a 0.7%...

Yes I find this company compelling, but when the Investment Director of The Oxford Club, Alexander Green likes a company with this description, I go from interested to confident. Alex's track record is amazing, and I'm a big fan of his trading service, The Momentum Alert.Yesterday Alex wrote to me...

The Law Office of Abe Shainberg is investigating the Board of Directors of Matrixx Initiatives (NASDAQ: MTXX) for possible breaches of fiduciary duty and other violations of state law in connection with the proposal from H.I.G. Capital, LLC. to acquire all outstanding shares of Matrixx. Under the...

The Consumer Price Index (CPI) rose by just 0.1% in November, down from 0.2% October. Even with the 0.1% increase in September, year over year it is up just 1.1%. Energy prices, were surprisingly well behaved in the month, rising just 0.2% after having surged 2.6% in October on top of a 0.7%...

Shares of Buffalo Grove, Illinois-based Akorn, Inc. (Nasdaq: AKRX) are trading up 12.2% at $5.98 per share during the Wednesday afternoon trading session. The day's trading range for shares of Akorn, Inc has been between $5.38 and a 52-week high of $6.11 per share. Analysts covering Akorn, Inc. (...

Shares of Cypress Bioscience, Inc. (Nasdaq: CYPB) are trading up 12.2% at $6.45 per share during the Wednesday afternoon trading session. The company announced on Wednesday before the market opened that it has agreed to a takeover bid of $6.50 per share in cash, or $255 million total, from Ramius...

UCB (UCBJF) along with partner Immunomedics Inc. (IMMU) recently started patient enrollment in a late-stage trial of epratuzumab in patients with moderate-to-severe systemic lupus erythematosus (SLE). The trial (EMBODY 1) is one of two pivotal phase III trials. The second study, EMBODY 2, has...

US tech stocks rose, with the Nasdaq Composite Index gaining about 0.28%. The gainers in the list included Apple Inc (NASDAQ: AAPL) and Cisco Systems Inc (NASDAQ: CSCO). Shares of Broadcom Corp. (NASDAQ: BRCM) declined about 2% after the company gave a mixed Q4 outlook. Shares of Cypress Bioscience...

Recently, Novartis AG (NVS) presented data from the AZURE trial of its bone drug Zometa at the annual Antonio Breast Cancer Symposium. The phase III study tested the effectiveness of Zometa in improving disease free survival in both premenopausal and postmenopausal women with early breast cancer...

UCB (UCBJF) along with partner Immunomedics Inc. (IMMU) recently started patient enrollment in a late-stage trial of epratuzumab in patients with moderate-to-severe systemic lupus erythematosus (SLE). The trial (EMBODY 1) is one of two pivotal phase III trials. The second study, EMBODY 2, has...